Dr Reddy's COO On US Derma Build-Up, One-Sided Biologics Norms

Dr Reddy's Laboratories (DRL) appears to be building on plans for its differentiated dermatology and neurology formulations in the US after gains on the approvals front.

More from Dermatological

More from Therapy Areas